Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized? - Global News | Canada News Media
Connect with us

Business

Pfizer’s COVID pill is in short supply. Should unvaccinated be prioritized? – Global News

Published

 on


With a limited supply of Pfizer’s new COVID-19 treatment, Paxlovid, bound for Canada, the country’s top doctors have identified groups that should be first in line to get the pills — including unvaccinated older Canadians.

Giving unvaccinated Canadians access to this COVID-19 medication isn’t only the right thing to do, it’s smart public health policy, says one bioethicist.

“It would be ethically unjustifiable, and it would not be scientifically sound to withhold this limited drug from unvaccinated people,” said Dr. Kerry Bowman, a bioethicist at the University of Toronto.

In clinical trial data submitted to Health Canada, the drug was found to reduce risk of hospitalization and death by 89 per cent, according to Dr. Supriya Sharma, Canada’s chief medical adviser.

Read more:

Canada approved Paxlovid, Pfizer’s new oral COVID pill. What you need to know

Ethically speaking, Bowman explained, it’s “very dangerous” to make “judgments” about choices patients make, as well as “about how much health care they can receive based on the choices that they made.”

“It would be a dangerous precedent, and it’s not in alignment with the Canada Health Act,” Bowman said.

As for the science, keeping people out of the hospitals — unvaccinated or not — is key to emerging from the pandemic, he explained.

“From a triage point of view, (vaccination status) is not relevant information…we don’t want highly sick people in the intensive care unit with COVID that don’t have to be there,” Bowman said.

“And so if, in fact, you could avert some of the unvaccinated entering our ICU and taking up space, which is what everyone’s upset and complaining about, all the more reason to do that.”






1:34
COVID-19: O’Toole says Pfizer’s Paxlovid shipment of 30,000 treatment courses is ‘insufficient’


COVID-19: O’Toole says Pfizer’s Paxlovid shipment of 30,000 treatment courses is ‘insufficient’

Very few courses of this treatment are arriving in Canada in the weeks ahead. Canada has already received an initial shipment of 30,400 treatment courses, Procurement Minister Filomena Tassi said on Monday, and 120,000 more are expected to be delivered between now and the end of March.

There are over 330,000 active cases of the COVID-19 confirmed across the country right now, though that’s considered to be an underestimate.

But far from being the best option for all of those active cases, Paxlovid is only an effective treatment option for a small group of people in Canada to begin with, according to Health Canada. To receive a course of the COVID-19 treatment, an individual must be over 18, and must first test positive for COVID, either with a PCR or a rapid antigen test.

The person must also be within their first five days of having symptoms, and be sick enough to need the medicine without being so sick they need to go to the hospital.

“Paxlovid is just yet another piece of the puzzle that helps us manage this illness in people who may be at more risk,” said Dr. Gerald Evans, an infectious disease specialist at Queen’s University in Kingston, Ont. “For instance, those very small few who are not vaccinated at the moment.”

Read more:

Paxlovid, Pfizer’s oral COVID-19 pill, approved in Canada

Evans added that if you are fully vaccinated, you probably shouldn’t be concerned about others having access to Paxlovid before you.

“If you’re fully vaccinated, you don’t need this drug,” Evans said.

“The effectiveness of vaccination is clearly better than it is for a new antiviral medication like this that’s come out. So being fully vaccinated, you’re way ahead of the game.”

Some individuals who are fully vaccinated might find themselves needing the treatment, such as “an elderly person with a solid organ transplant,” Evans said, but those people are the exception, not the rule.

Who gets priority access to Paxlovid?

The final priority list will be up to the provinces and territories to decide, Health Canada said on Tuesday, but the federal government has provided those regions with “interim implementation considerations” for the first batches of Paxlovid that have arrived.

“(The) first consideration is prioritizing individuals who are at the highest risk for severe illness and hospitalizations,” said Anne Génier, a spokesperson for Health Canada.

Those individuals, Genier added, include immunocompromised Canadians, those over 60 who live in certain at-risk settings and aren’t fully vaccinated, and those over 80 “whose vaccinations are not up to date.”






1:59
When will Pfizer COVID-19 antiviral treatment arrive in B.C.?


When will Pfizer COVID-19 antiviral treatment arrive in B.C.?

Global News contacted every province and territory to determine the criteria they’ll use in deciding who gets first access to the limited supply of Paxlovid.

In Quebec, people who are immunocompromised will be given priority access to the treatment, regardless of their vaccination status, a spokesperson told Global News. New Brunswick’s government, meanwhile, said Paxlovid “will only be provided to individuals who are among the public health priority groups for the time being.”






1:24
COVID-19: Canada has already received 1st shipment of Pfizer antiviral pill, procurement minister says


COVID-19: Canada has already received 1st shipment of Pfizer antiviral pill, procurement minister says

Nova Scotia, Ontario, Alberta and British Columbia did not provide specifics on their priority groups. However, Ontario, Alberta and B.C. all said they are currently working to determine eligibility and would have more details to share in the near future.

Manitoba did not directly answer Global News’ question. Newfoundland and Labrador, Prince Edward Island, Saskatchewan, Northwest Territories, Nunavut and Yukon governments did not respond by the time of publication.

At the end of the day, Paxlovid is just another tool in the pandemic toolbox, said Evans.

“I don’t think this is a game changer,” he said.

“What this is about, is yet another very effective tool we can use in a portion of the population.”

© 2022 Global News, a division of Corus Entertainment Inc.

Adblock test (Why?)



Source link

Continue Reading

Business

Netflix’s subscriber growth slows as gains from password-sharing crackdown subside

Published

 on

 

Netflix on Thursday reported that its subscriber growth slowed dramatically during the summer, a sign the huge gains from the video-streaming service’s crackdown on freeloading viewers is tapering off.

The 5.1 million subscribers that Netflix added during the July-September period represented a 42% decline from the total gained during the same time last year. Even so, the company’s revenue and profit rose at a faster pace than analysts had projected, according to FactSet Research.

Netflix ended September with 282.7 million worldwide subscribers — far more than any other streaming service.

The Los Gatos, California, company earned $2.36 billion, or $5.40 per share, a 41% increase from the same time last year. Revenue climbed 15% from a year ago to $9.82 billion. Netflix management predicted the company’s revenue will rise at the same 15% year-over-year pace during the October-December period, slightly than better than analysts have been expecting.

The strong financial performance in the past quarter coupled with the upbeat forecast eclipsed any worries about slowing subscriber growth. Netflix’s stock price surged nearly 4% in extended trading after the numbers came out, building upon a more than 40% increase in the company’s shares so far this year.

The past quarter’s subscriber gains were the lowest posted in any three-month period since the beginning of last year. That drop-off indicates Netflix is shifting to a new phase after reaping the benefits from a ban on the once-rampant practice of sharing account passwords that enabled an estimated 100 million people watch its popular service without paying for it.

The crackdown, triggered by a rare loss of subscribers coming out of the pandemic in 2022, helped Netflix add 57 million subscribers from June 2022 through this June — an average of more than 7 million per quarter, while many of its industry rivals have been struggling as households curbed their discretionary spending.

Netflix’s gains also were propelled by a low-priced version of its service that included commercials for the first time in its history. The company still is only getting a small fraction of its revenue from the 2-year-old advertising push, but Netflix is intensifying its focus on that segment of its business to help boost its profits.

In a letter to shareholder, Netflix reiterated previous cautionary notes about its expansion into advertising, though the low-priced option including commercials has become its fastest growing segment.

“We have much more work to do improving our offering for advertisers, which will be a priority over the next few years,” Netflix management wrote in the letter.

As part of its evolution, Netflix has been increasingly supplementing its lineup of scripted TV series and movies with live programming, such as a Labor Day spectacle featuring renowned glutton Joey Chestnut setting a world record for gorging on hot dogs in a showdown with his longtime nemesis Takeru Kobayashi.

Netflix will be trying to attract more viewer during the current quarter with a Nov. 15 fight pitting former heavyweight champion Mike Tyson against Jake Paul, a YouTube sensation turned boxer, and two National Football League games on Christmas Day.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

All Magic Spells (TM) : Top Converting Magic Spell eCommerce Store

Published

 on

Product Name: All Magic Spells (TM) : Top Converting Magic Spell eCommerce Store

Click here to get All Magic Spells (TM) : Top Converting Magic Spell eCommerce Store at discounted price while it’s still available…

All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

All Magic Spells (TM) : Top Converting Magic Spell eCommerce Store is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.

(more…)

Continue Reading

Business

CPC Practice Exam

Published

 on

Product Name: CPC Practice Exam

Click here to get CPC Practice Exam at discounted price while it’s still available…

All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

CPC Practice Exam is backed with a 60 Day No Questions Asked Money Back Guarantee. If within the first 60 days of receipt you are not satisfied with Wake Up Lean™, you can request a refund by sending an email to the address given inside the product and we will immediately refund your entire purchase price, with no questions asked.

(more…)

Continue Reading

Trending

Exit mobile version